Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Commerce/Health Subcommittee to mark-up FDA reform measure Sept. 17.

This article was originally published in The Tan Sheet

Executive Summary

HOUSE NATIONAL UNIFORMITY PROVISION MIRRORING SENATE LANGUAGE will be added as an amendment to HR 1411 during a scheduled Sept. 17 mark-up by the House Commerce/Health Subcommittee. Although a "discussion draft" version of the Commerce Committee's Prescription Drug User Fee Reauthorization and Drug Modernization bill includes a "national uniformity" heading, specific language was omitted pending a Senate compromise on uniformity provisions for cosmetics.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087522

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel